ORIGINAL RESEARCH
Published on 25 Nov 2025
Development and validation of the FAAP model for prognostic stratification in HCC patients treated with TACE, sintilimab plus bevacizumab: a multicenter study
doi 10.3389/fimmu.2025.1692632
- 298 views
- Frontiers in Medicine
- Hepatobiliary Diseases
- Research Topics
- New Strategies and Clinical Translation Progress in Immunotherapy for Liver Cancer
New Strategies and Clinical Translation Progress in Immunotherapy for Liver Cancer
111
Total downloads
4,469
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 11 Nov 2025
TACE-HAlC combined with Donafenib and immune checkpoint inhibitors for BCLC stage C HCC patients (THEME study): a retrospective IPTW-adjusted cohort study
doi 10.3389/fimmu.2025.1669856
- 430 views
ORIGINAL RESEARCH
Published on 10 Nov 2025
Stereotactic body radiation therapy combined with cadonilimab and lenvatinib in the treatment of hepatocellular carcinoma with Vp3 or Vp4 portal vein tumor thrombus: a prospective, multicenter, single-arm, phase II clinical trial
doi 10.3389/fimmu.2025.1687344
- 425 views
SYSTEMATIC REVIEW
Published on 29 Oct 2025
Navigating the risks: a systematic review of immune checkpoint inhibitor therapy before liver transplant for hepatocellular carcinoma and its impact on allograft rejection and survival outcomes
doi 10.3389/fonc.2025.1689820
- 1,022 views
CASE REPORT
Published on 23 Oct 2025
Effective control in MSI-high unresectable intrahepatic cholangiocarcinoma treated with gemcitabine/cisplatin/durvalumab and proton beam therapy: a case report
doi 10.3389/fimmu.2025.1685944
- 1,042 views
Published in
Frontiers in Medicine
Hepatobiliary Diseases
Other participating journals
Frontiers in Immunology
- 5.9 impact factor
- 10.8 citescore
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: